On the public citation graph

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

https://doi.org/10.1126/science.aan6733
0 signed · 6661 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1097-0142(20010615)91:12<2417::aid-cncr1276>3.0.co;2-uopenalex-snapshot
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
inferredcites →https://doi.org/10.1016/0022-2836(70)90057-4openalex-snapshot
A general method applicable to the search for similarities in the amino acid sequence of two proteins
inferredcites →https://doi.org/10.1016/bs.ai.2016.01.001openalex-snapshot
The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer
inferredcites →https://doi.org/10.1016/j.ccell.2015.03.001openalex-snapshot
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
inferredcites →https://doi.org/10.1016/j.cell.2016.02.065openalex-snapshot
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
inferredcites →https://doi.org/10.1016/j.cell.2017.01.010openalex-snapshot
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
inferredcites →https://doi.org/10.1016/s0002-9440(10)65436-3openalex-snapshot
High Prevalence of Activated Intraepithelial Cytotoxic T Lymphocytes and Increased Neoplastic Cell Apoptosis in Colorectal Carcinomas with Microsatellite Instability
inferredcites →https://doi.org/10.1016/s0140-6736(12)61900-xopenalex-snapshot
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
inferredcites →https://doi.org/10.1038/25292openalex-snapshot
Genetic instabilities in human cancers
inferredcites →https://doi.org/10.1038/nature13954openalex-snapshot
PD-1 blockade induces responses by inhibiting adaptive immune resistance
inferredcites →https://doi.org/10.1038/nature13988openalex-snapshot
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
inferredcites →https://doi.org/10.1038/nature14011openalex-snapshot
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
inferredcites →https://doi.org/10.1038/ncomms3680openalex-snapshot
Using synthetic templates to design an unbiased multiplex PCR assay
inferredcites →https://doi.org/10.1038/ng.2493openalex-snapshot
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
inferredcites →https://doi.org/10.1038/nm.4191openalex-snapshot
Classification and characterization of microsatellite instability across 18 cancer types
inferredcites →https://doi.org/10.1056/nejmoa1500596openalex-snapshot
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
inferredcites →https://doi.org/10.1056/nejmoa1604958openalex-snapshot
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
inferredcites →https://doi.org/10.1126/science.aaa1348openalex-snapshot
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
inferredcites →https://doi.org/10.1126/science.aaa4971openalex-snapshot
Neoantigens in cancer immunotherapy
inferredcites →https://doi.org/10.1126/scitranslmed.3003689openalex-snapshot
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
inferredcites →https://doi.org/10.1126/scitranslmed.aaa7161openalex-snapshot
Personalized genomic analyses for cancer mutation discovery and interpretation
inferredcites →https://doi.org/10.1155/2004/136734openalex-snapshot
Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
inferredcites →https://doi.org/10.1158/0008-5472.can-07-3095openalex-snapshot
Epitope Landscape in Breast and Colorectal Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1624openalex-snapshot
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-3271openalex-snapshot
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
inferredcites →https://doi.org/10.1158/2159-8290.cd-14-0863openalex-snapshot
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
inferredcites →https://doi.org/10.1158/2159-8290.cd-16-0828openalex-snapshot
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1159/000430097openalex-snapshot
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1182/blood-2009-04-217604openalex-snapshot
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
inferredcites →https://doi.org/10.1200/jco.2013.53.0105openalex-snapshot
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
inferredcites →https://doi.org/10.1200/jco.2014.58.1041openalex-snapshot
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
inferredcites →https://doi.org/10.1200/jco.2014.58.3708openalex-snapshot
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1200/jco.2017.35.4_suppl.519openalex-snapshot
Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142.
inferredcites →https://doi.org/10.2353/jmoldx.2006.050092openalex-snapshot
Comparison of the Microsatellite Instability Analysis System and the Bethesda Panel for the Determination of Microsatellite Instability in Colorectal Cancers

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3782439openalex-extracted
Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With dMMR Metastatic Colorectal Cancer: A Multicenter Cohort Study
inferred← citeshttps://doi.org/10.2139/ssrn.4047654openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4059524openalex-extracted
Distinct Mechanisms of Mismatch Repair Deficiency Delineate Two Modes of Response to PD-1 Immunotherapy in Endometrial Carcinoma
inferred← citeshttps://doi.org/10.2139/ssrn.4068373openalex-extracted
Deep Learning-Assisted Colonoscopy Images for Prediction of Mismatch Repair Deficiency in Colorectal Cancer: A Diagnostic Study
inferred← citeshttps://doi.org/10.2139/ssrn.4195922openalex-extracted
CXCL13 Modulates Immunoactive Tumor Microenvironment and Improves Prognosis in Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jama.2020.20457openalex-snapshot
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma
inferred← citeshttps://doi.org/10.1001/jama.2021.0106openalex-snapshot
Diagnosis and Treatment of Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.11818openalex-snapshot
Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non–small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.11113openalex-snapshot
Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non–Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.13077openalex-snapshot
Paired Tumor-Germline Testing as a Driver in Better Cancer Care
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.43457openalex-snapshot
Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.0400openalex-snapshot
Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.0631openalex-snapshot
Evaluation of Systemic Treatments of Small Intestinal Adenocarcinomas
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.41165openalex-snapshot
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.23186openalex-snapshot
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.27769openalex-snapshot
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2017.3323openalex-snapshot
Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2017.4182openalex-snapshot
Cancer Drugs Approved Based on Biomarkers and Not Tumor Type—FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers
inferred← citeshttps://doi.org/10.1001/jamaoncol.2018.1482openalex-snapshot
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome
inferred← citeshttps://doi.org/10.1001/jamaoncol.2018.2805openalex-snapshot
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2018.4942openalex-snapshot
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
inferred← citeshttps://doi.org/10.1001/jamaoncol.2018.5789openalex-snapshot
Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2018.5801openalex-snapshot
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.1583openalex-snapshot
Dual Checkpoint Inhibition in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.5963openalex-snapshot
An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.6152openalex-snapshot
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.0910openalex-snapshot
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.0930openalex-snapshot
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.1046openalex-snapshot
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.3370openalex-snapshot
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.4515openalex-snapshot
Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.7987openalex-snapshot
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.8072openalex-snapshot
Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas
inferred← citeshttps://doi.org/10.1001/jamaoncol.2021.0275openalex-snapshot
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
inferred← citeshttps://doi.org/10.1001/jamaoncol.2021.2350openalex-snapshot
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA
inferred← citeshttps://doi.org/10.1001/jamaoncol.2022.3707openalex-snapshot
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2022.6708openalex-snapshot
Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer—Reply
inferred← citeshttps://doi.org/10.1001/jamaoncol.2023.3323openalex-snapshot
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2024.3651openalex-snapshot
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
inferred← citeshttps://doi.org/10.1001/jamasurg.2017.3895openalex-snapshot
Progress in the March to Precision Cancer Medicine
inferred← citeshttps://doi.org/10.1002/14651858.cd013369openalex-snapshot
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first- or second-line treatment of advanced gastric and gastro-esophageal junction cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.12467openalex-snapshot
Exploiting DNA repair defects in colorectal cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.12663openalex-snapshot
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
inferred← citeshttps://doi.org/10.1002/1878-0261.12739openalex-snapshot
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
inferred← citeshttps://doi.org/10.1002/1878-0261.12791openalex-snapshot
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
inferred← citeshttps://doi.org/10.1002/1878-0261.12868openalex-snapshot
Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets
inferred← citeshttps://doi.org/10.1002/1878-0261.13173openalex-snapshot
Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study
inferred← citeshttps://doi.org/10.1002/1878-0261.70173openalex-snapshot
TREX1 , a predator for treating MSI ‐H tumors?
inferred← citeshttps://doi.org/10.1002/2056-4538.70025openalex-snapshot
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm003.pub2openalex-snapshot
Molecular Biology, Genetics, and Translational Models of Human Cancer
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm040.pub2openalex-snapshot
Clinical Cancer Genomic Diagnostics and Modern Diagnostic Pathology
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm104.pub3openalex-snapshot
Endometrial Cancer
inferred← citeshttps://doi.org/10.1002/9781119126843.ch6openalex-snapshot
Targeted Treatments for Common Solid Tumors
inferred← citeshttps://doi.org/10.1002/9781119432487.ch1openalex-snapshot
Genomic Strategies for Personalized Cancer Therapy
inferred← citeshttps://doi.org/10.1002/9781119535331.ch2openalex-snapshot
Genetically Engineered Mouse Models ( GEMMs ) in Cancer Immunotherapy R&D
inferred← citeshttps://doi.org/10.1002/9781119570097.ch54openalex-snapshot
Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice
inferred← citeshttps://doi.org/10.1002/9781119570097.ch65openalex-snapshot
Chemotherapy for Nonresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/9781119756422.ch10openalex-snapshot
Genomics, Histopathology, and Molecular Pathology of Sporadic and Hereditary Colorectal Cancer
inferred← citeshttps://doi.org/10.1002/9781119834090.ch5openalex-snapshot
Immunotherapy with Checkpoint Inhibitors
inferred← citeshttps://doi.org/10.1002/9781119876007.ch122openalex-snapshot
Molecular Subtypes and Clinical Applications
inferred← citeshttps://doi.org/10.1002/9781119876007.ch124openalex-snapshot
Familial Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/9783527838561.ch20openalex-snapshot
Penile Cancer
inferred← citeshttps://doi.org/10.1002/9783527838561.ch21openalex-snapshot
Testicular Cancer
inferred← citeshttps://doi.org/10.1002/9783527838561.ch6openalex-snapshot
Breast Cancer
inferred← citeshttps://doi.org/10.1002/adbi.201900236openalex-snapshot
Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/adbi.202101319openalex-snapshot
Understanding Suboptimal Response to Immune Checkpoint Inhibitors
inferred← citeshttps://doi.org/10.1002/adfm.201802847openalex-snapshot
Nanoparticle‐mediated HMGA1 Silencing Promotes Lymphocyte Infiltration and Boosts Checkpoint Blockade Immunotherapy for Cancer
inferred← citeshttps://doi.org/10.1002/adfm.202509165openalex-snapshot
Inhibiting Senescence‐Associated Macrophage‐Epithelia Cell Communication via siPLAU Gene‐Patch for Colorectal Cancer Treatment
inferred← citeshttps://doi.org/10.1002/adhm.202503114openalex-snapshot
Targeting PIN1 in Pancreatic Tumor Microenvironment with Peptide Amphiphiles Unleashes Immune Checkpoint Therapy
inferred← citeshttps://doi.org/10.1002/adma.201805007openalex-snapshot
Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
inferred← citeshttps://doi.org/10.1002/adma.201905823openalex-snapshot
Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications
inferred← citeshttps://doi.org/10.1002/adma.202310522openalex-snapshot
A “One Arrow Three Eagle” Strategy to Improve CM‐272 Primed Bladder Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adtp.201900167openalex-snapshot
Phenotypic Response and Personalized Medicine in Liver Cancer and Transplantation: Approaches to Complex Systems
inferred← citeshttps://doi.org/10.1002/adtp.201900200openalex-snapshot
Immunostimulatory TLR7 Agonist‐Nanoparticles Together with Checkpoint Blockade for Effective Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202100166openalex-snapshot
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
inferred← citeshttps://doi.org/10.1002/advs.202207155openalex-snapshot
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
inferred← citeshttps://doi.org/10.1002/advs.202300348openalex-snapshot
Single‐Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell Cancer Identifies Neural‐Like Progenitor Program Associated with the Efficacy of Radiotherapy
inferred← citeshttps://doi.org/10.1002/advs.202303753openalex-snapshot
Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single‐Cell Transcriptomics
inferred← citeshttps://doi.org/10.1002/advs.202306889openalex-snapshot
A Thermosensitive Bi‐Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti‐Tumor Efficacy of Frameshift Neoantigens
inferred← citeshttps://doi.org/10.1002/advs.202307130openalex-snapshot
Employing Piezoelectric Mg 2+ ‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation
inferred← citeshttps://doi.org/10.1002/advs.202310308openalex-snapshot
Inhibition of Glutamate‐to‐Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells
inferred← citeshttps://doi.org/10.1002/advs.202402816openalex-snapshot
GHCU, a Molecular Chaperone, Regulates Leaf Curling by Modulating the Distribution of KNGH1 in Cotton
inferred← citeshttps://doi.org/10.1002/advs.202506518openalex-snapshot
Tumor‐Derived CDC37 Inhibits Antigen Cross‐Presentation in Dendritic Cells and Impairs Anti‐Tumor Immunity in Breast Cancer
inferred← citeshttps://doi.org/10.1002/advs.202508040openalex-snapshot
Personalized Neoantigen Vaccine plus Regorafenib Increases Rgs2⁺CD8⁺ T Cells Infiltration and Reprograms the Tumor Microenvironment in Microsatellite Stable Colorectal Cancer Liver Metastases
inferred← citeshttps://doi.org/10.1002/advs.202513567openalex-snapshot
Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202514600openalex-snapshot
MARCO+ Tumor‐Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma
inferred← citeshttps://doi.org/10.1002/advs.76020openalex-snapshot
Advances in Cancer Immunotherapy for Solid Tumors
inferred← citeshttps://doi.org/10.1002/advs.76143openalex-snapshot
Single‐Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti‐PD‐1 Resistance in Colorectal Cancer
inferred← citeshttps://doi.org/10.1002/advs.77594openalex-snapshot
TGFBI Maintains Fibrocartilage Homeostasis by Restraining O‐GlcNAcylation to Inactivate and Destabilize ADAMTS16 in Temporomandibular Joint Osteoarthritis
inferred← citeshttps://doi.org/10.1002/advs.78005openalex-snapshot
Transformer‐Based Multitask Framework Integrating Habitat and Deep Learning for Predicting Early Disease Control and Survival in Immunotherapy‐Treated Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/ags3.12180openalex-snapshot
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
inferred← citeshttps://doi.org/10.1002/ags3.12334openalex-snapshot
Genetic analysis in the clinical management of biliary tract cancer
inferred← citeshttps://doi.org/10.1002/ags3.12436openalex-snapshot
Recent advances in precision medicine for pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/ags3.12482openalex-snapshot
Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population
inferred← citeshttps://doi.org/10.1002/ags3.12526openalex-snapshot
The impact of DNA testing on management of patients with colorectal cancer
inferred← citeshttps://doi.org/10.1002/ajh.26835openalex-snapshot
Sequence analyses of relapsed or refractory diffuse large B‐cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH‐EP1 study
inferred← citeshttps://doi.org/10.1002/ame2.70069openalex-snapshot
Establishment and molecular profiling of a PDX model of a metachronous brain tumor in a patient with constitutional mismatch repair deficiency with biallelic MSH6 variant
inferred← citeshttps://doi.org/10.1002/bjs.10726openalex-snapshot
Patient-derived organoid models help define personalized management of gastrointestinal cancer
inferred← citeshttps://doi.org/10.1002/bjs.10871openalex-snapshot
Gene expression profiles for a prognostic immunoscore in gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.10993openalex-snapshot
Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11204openalex-snapshot
Mechanisms of immunogenicity in colorectal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11224openalex-snapshot
Immuno-oncology for surgeons
inferred← citeshttps://doi.org/10.1002/bjs5.91openalex-snapshot
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer
inferred← citeshttps://doi.org/10.1002/cac2.12193openalex-snapshot
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
inferred← citeshttps://doi.org/10.1002/cac2.12199openalex-snapshot
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis
inferred← citeshttps://doi.org/10.1002/cac2.12295openalex-snapshot
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
inferred← citeshttps://doi.org/10.1002/cac2.12548openalex-snapshot
Protein tyrosine phosphatases: emerging role in cancer therapy resistance
inferred← citeshttps://doi.org/10.1002/cai2.60openalex-snapshot
Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022
inferred← citeshttps://doi.org/10.1002/cam4.1372openalex-snapshot
Microsatellite instability status determined by next‐generation sequencing and compared with PD ‐L1 and tumor mutational burden in 11,348 patients
inferred← citeshttps://doi.org/10.1002/cam4.1663openalex-snapshot
Prognostic significance of nomograms integrating IL‐37 expression, neutrophil level, and MMR status in patients with colorectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.1722openalex-snapshot
Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
inferred← citeshttps://doi.org/10.1002/cam4.2191openalex-snapshot
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
inferred← citeshttps://doi.org/10.1002/cam4.2381openalex-snapshot
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
inferred← citeshttps://doi.org/10.1002/cam4.2602openalex-snapshot
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
inferred← citeshttps://doi.org/10.1002/cam4.2763openalex-snapshot
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.2849openalex-snapshot
Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer
inferred← citeshttps://doi.org/10.1002/cam4.2870openalex-snapshot
Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma
inferred← citeshttps://doi.org/10.1002/cam4.3294openalex-snapshot
Population bias in somatic measurement of microsatellite instability status
inferred← citeshttps://doi.org/10.1002/cam4.3376openalex-snapshot
TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti‐CTLA4 treatment
inferred← citeshttps://doi.org/10.1002/cam4.3619openalex-snapshot
Comprehensive molecular profiling broadens treatment options for breast cancer patients
inferred← citeshttps://doi.org/10.1002/cam4.3630openalex-snapshot
A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.3655openalex-snapshot
Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.3679openalex-snapshot
Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes
inferred← citeshttps://doi.org/10.1002/cam4.3723openalex-snapshot
Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens
inferred← citeshttps://doi.org/10.1002/cam4.3828openalex-snapshot
Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer
inferred← citeshttps://doi.org/10.1002/cam4.3957openalex-snapshot
Development and validation of MRI‐based deep learning models for prediction of microsatellite instability in rectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.3987openalex-snapshot
Comparative genomic signatures in young and old Chinese patients with colorectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.4078openalex-snapshot
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2
inferred← citeshttps://doi.org/10.1002/cam4.4472openalex-snapshot
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
inferred← citeshttps://doi.org/10.1002/cam4.5085openalex-snapshot
Hyperthermia combined with immune checkpoint inhibitor therapy: Synergistic sensitization and clinical outcomes
inferred← citeshttps://doi.org/10.1002/cam4.5354openalex-snapshot
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort
inferred← citeshttps://doi.org/10.1002/cam4.5403openalex-snapshot
Establishment of a gastric cancer cell line with high microsatellite instability, OCUM ‐13, derived from Borrmann type‐2 primary tumor
inferred← citeshttps://doi.org/10.1002/cam4.5429openalex-snapshot
T cell‐inflamed gene expression profile is associated with favorable disease‐specific survival in non‐hypermutated microsatellite‐stable colorectal cancer patients
inferred← citeshttps://doi.org/10.1002/cam4.5888openalex-snapshot
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population
inferred← citeshttps://doi.org/10.1002/cam4.6000openalex-snapshot
LAG ‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics
inferred← citeshttps://doi.org/10.1002/cam4.6270openalex-snapshot
Cuproptosis‐related miRNAs signature and immune infiltration characteristics in colorectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.6765openalex-snapshot
The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD‐L1 expression
inferred← citeshttps://doi.org/10.1002/cam4.6910openalex-snapshot
Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study
inferred← citeshttps://doi.org/10.1002/cam4.70960openalex-snapshot
Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.7115openalex-snapshot
Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel
inferred← citeshttps://doi.org/10.1002/cam4.71442openalex-snapshot
Prognostic Implications of SMARCA4 , ARID1A , and Other BAF Mutations in Non‐Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1002/cam4.7154openalex-snapshot
Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center
inferred← citeshttps://doi.org/10.1002/cam4.71817openalex-snapshot
The Keynote‐177 Randomized Controlled Trial of First‐line PD ‐1 Blockade for Microsatellite‐High or Mismatch Repair‐Deficient Advanced Colorectal Cancer: Potential Consequences of the Cross‐Over Trial Design and Related Issues
inferred← citeshttps://doi.org/10.1002/cam4.72095openalex-snapshot
Association of the PD ‐ L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
inferred← citeshttps://doi.org/10.1002/cam4.7218openalex-snapshot
Artificial neural network identified a 20‐gene panel in predicting immunotherapy response and survival benefits after anti‐PD1 / PD‐L1 treatment in glioblastoma patients
inferred← citeshttps://doi.org/10.1002/cbf.70011openalex-snapshot
Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects
inferred← citeshttps://doi.org/10.1002/cbf.70196openalex-snapshot
Comprehensive Overview of Therapeutic Strategies in Colon Cancer: Chemotherapy, Targeted Therapy, and Immunotherapy
inferred← citeshttps://doi.org/10.1002/ccr3.4008openalex-snapshot
Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
inferred← citeshttps://doi.org/10.1002/ccr3.6194openalex-snapshot
A primary squamous cell carcinoma of the sigmoid colon in a young patient: A case report and literature review
inferred← citeshttps://doi.org/10.1002/ccr3.7747openalex-snapshot
Management of PALB2 ‐associated breast cancer: A literature review and case report
inferred← citeshttps://doi.org/10.1002/cjp2.113openalex-snapshot
Cancer immunophenotyping by seven‐colour multispectral imaging without tyramide signal amplification
inferred← citeshttps://doi.org/10.1002/cjp2.260openalex-snapshot
Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cjp2.271openalex-snapshot
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
inferred← citeshttps://doi.org/10.1002/cjp2.303openalex-snapshot
Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes
inferred← citeshttps://doi.org/10.1002/cncr.31105openalex-snapshot
Immune checkpoint inhibitors in advanced non–small cell lung cancer
inferred← citeshttps://doi.org/10.1002/cncr.31214openalex-snapshot
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine
inferred← citeshttps://doi.org/10.1002/cncr.31345openalex-snapshot
Melanoma: What do all the mutations mean?
inferred← citeshttps://doi.org/10.1002/cncr.31795openalex-snapshot
Cost‐effectiveness of immune checkpoint inhibitors for microsatellite instability–high/mismatch repair–deficient metastatic colorectal cancer
inferred← citeshttps://doi.org/10.1002/cncr.31855openalex-snapshot
Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China
inferred← citeshttps://doi.org/10.1002/cncr.31951openalex-snapshot
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes
inferred← citeshttps://doi.org/10.1002/cncr.32058openalex-snapshot
Microsatellite instability in endometrial cancer: New purpose for an old test
inferred← citeshttps://doi.org/10.1002/cncr.32351openalex-snapshot
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
inferred← citeshttps://doi.org/10.1002/cncr.33172openalex-snapshot
Immune responses in genomically simple SWI/SNF–deficient cancers
inferred← citeshttps://doi.org/10.1002/cncr.33284openalex-snapshot
Academics as leaders in the cancer artificial intelligence revolution
inferred← citeshttps://doi.org/10.1002/cncr.34025openalex-snapshot
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
inferred← citeshttps://doi.org/10.1002/cncr.34717openalex-snapshot
Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile
inferred← citeshttps://doi.org/10.1002/cncr.35067openalex-snapshot
Attack of the clones: Unveiling subclonal/heterogenous mismatch repair/microsatellite instability status in endometrial cancer
inferred← citeshttps://doi.org/10.1002/cncr.35071openalex-snapshot
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry
inferred← citeshttps://doi.org/10.1002/cncr.35267openalex-snapshot
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair‐deficient and microsatellite instability‐high endometrial cancers
inferred← citeshttps://doi.org/10.1002/cncr.35726openalex-snapshot
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer
inferred← citeshttps://doi.org/10.1002/cncr.35882openalex-snapshot
Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer
inferred← citeshttps://doi.org/10.1002/cncr.35888openalex-snapshot
Recent advances in gynecologic radiation oncology
inferred← citeshttps://doi.org/10.1002/cncy.22640openalex-snapshot
Beyond PD‐L1 : Assessment of LAG ‐3 and other predictive biomarkers in non–small cell lung carcinoma
inferred← citeshttps://doi.org/10.1002/cnr2.1894openalex-snapshot
Tumor‐infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer
inferred← citeshttps://doi.org/10.1002/cnr2.70037openalex-snapshot
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy‐Responsive Locally Advanced Rectal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cnr2.70492openalex-snapshot
Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment
inferred← citeshttps://doi.org/10.1002/cpt.1946openalex-snapshot
Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine
inferred← citeshttps://doi.org/10.1002/cpz1.377openalex-snapshot
In Vivo Modeling of Tumor Heterogeneity for Immuno‐Oncology Studies: Failures, Improvements, and Hopes
inferred← citeshttps://doi.org/10.1002/ctd2.70openalex-snapshot
Prognostic implication and immunological value of contactin 1 expression in pan‐cancer
inferred← citeshttps://doi.org/10.1002/ctd2.70174openalex-snapshot
Systemic immune‐inflammation indices and MSI‐H/dMMR status in colorectal cancer: Published evidence synthesis with exploratory local clinical and pathological corroboration
inferred← citeshttps://doi.org/10.1002/cti2.1050openalex-snapshot
Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma
inferred← citeshttps://doi.org/10.1002/cti2.1155openalex-snapshot
CD8+ tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival
inferred← citeshttps://doi.org/10.1002/cti2.1173openalex-snapshot
Systematic analysis of the transcriptome in small‐cell carcinoma of the oesophagus reveals its immune microenvironment
inferred← citeshttps://doi.org/10.1002/cti2.1215openalex-snapshot
The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
inferred← citeshttps://doi.org/10.1002/cti2.1347openalex-snapshot
SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers
inferred← citeshttps://doi.org/10.1002/cti2.70097openalex-snapshot
Characterisation of tumor‐infiltrating gamma‐delta T cells in human colorectal cancer with MHC‐I loss
inferred← citeshttps://doi.org/10.1002/ctm2.663openalex-snapshot
An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery
inferred← citeshttps://doi.org/10.1002/ctm2.70175openalex-snapshot
Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells
inferred← citeshttps://doi.org/10.1002/ctm2.70224openalex-snapshot
Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone
inferred← citeshttps://doi.org/10.1002/ctm2.70261openalex-snapshot
Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis
inferred← citeshttps://doi.org/10.1002/ctm2.853openalex-snapshot
TCR repertoire and transcriptional signatures of circulating tumour‐associated T cells facilitate effective non‐invasive cancer detection
inferred← citeshttps://doi.org/10.1002/cyto.a.23873openalex-snapshot
Multiparameter Flow Cytometry Assay for Quantification of Immune Cell Subsets, PD‐1 Expression Levels and PD‐1 Receptor Occupancy by Nivolumab and Pembrolizumab
inferred← citeshttps://doi.org/10.1002/dc.25306openalex-snapshot
Liquid biopsy of wash samples obtained via endoscopic ultrasound‐guided fine‐needle biopsy: Comparison with liquid biopsy of plasma in pancreatic cancer
inferred← citeshttps://doi.org/10.1002/deo2.365openalex-snapshot
Feasibility of comprehensive genomic profiling using endoscopic ultrasound‐guided tissue acquisition with a 22‐gauge Franseen needle
inferred← citeshttps://doi.org/10.1002/eji.202048747openalex-snapshot
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
inferred← citeshttps://doi.org/10.1002/eji.202451022openalex-snapshot
Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy
inferred← citeshttps://doi.org/10.1002/ejic.202400822openalex-snapshot
Synthesis of Gold(I) and Palladium(II) Complexes Bearing N‐Heterocyclic Carbene Thioglucosides with Selective Cytotoxicity Towards Ovarian Cancer Cells
inferred← citeshttps://doi.org/10.1002/ejic.70192openalex-snapshot
Stereochemical Modulation of Palladacyclopentadienyl Complexes Bearing Diphosphine Ligands: A Key to Enhanced DNA Interaction and Anticancer Activity
inferred← citeshttps://doi.org/10.1002/ejic.70285openalex-snapshot
Exploring the Anticancer Activity of Ruthenium(II)–Arene and Copper(I) Complexes Bearing N ‐Heterocyclic Carbene Ligands Containing Azido, Pyridinium, and Ethisterone‐Derived Triazole Groups
inferred← citeshttps://doi.org/10.1002/exp.20240183openalex-snapshot
Personalized Cancer Immunotherapy Boosted by cGAS‐STING‐Targeted Nanovaccines in Combination With Nutrient Modulation
showing the first 200 of 6625
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.